About Daniel Marshak
Form D filings for RareCyte from 2021 to 2023 list Daniel Marshak as director.
Daniel Marshak first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Marshak in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Marshak works with at each company, as listed on that company's latest Form D.
RareCyte, Inc. · Form D, Jul 25, 2023
DK
David Kabakoff
Director
RS
Ronald Seubert
Director
Robert Weisskoff
Director
JG
Jan Garfinkle
Director
AS
Andrew Schwab
Director
SR
Stephen Reichenbach
Executive officer
JJ
Joseph Victor Jr.
Chief Executive Officer and director